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Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a
New Host
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Maryland, USAa; Animal Health Diagnostic Center, College of Veterinary Medicine at Cornell, Ithaca, New York, USAb; Centre for Immunity, Infection and Evolution,
Ashworth Laboratories, University of Edinburgh, Edinburgh, United Kingdomc; Center for Infection and Immunity, Columbia University, New York, New York, USAd;
College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USAe; and Center for the Study of Hepatitis C, Laboratory of Virology and
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Genetic and biological characterization of new hepaciviruses infecting animals contributes to our understanding of the ultimate
origins of hepatitis C virus (HCV) infection in humans and dramatically enhances our ability to study its pathogenesis using
tractable animal models. Animal homologs of HCV include a recently discovered canine hepacivirus (CHV) and GB virus B
(GBV-B), both viruses with largely undetermined natural host ranges. Here we used a versatile serology-based approach to de-
termine the natural host of the only known nonprimate hepacivirus (NPHV), CHV, which is also the closest phylogenetic rela-
tive of HCV. Recombinant protein expressed from the helicase domain of CHVNS3 was used as antigen in the luciferase immu-
noprecipitation system (LIPS) assay to screen several nonprimate animal species. Thirty-six samples from 103 horses were
immunoreactive, and viral genomic RNAwas present in 8 of the 36 seropositive animals and none of the seronegative animals.
Complete genome sequences of these 8 genetically diverse NPHVs showed 14% (range, 6.4% to 17.2%) nucleotide sequence di-
vergence, with most changes occurring at synonymous sites. RNA secondary structure prediction of the 383-base 5= untranslated
region of NPHVwas refined and extended throughmapping of polymorphic sites to unpaired regions or (semi)covariant pair-
ings. Similar approaches were adopted to delineate extensive RNA secondary structures in the coding region of the genome, pre-
dicted to form 27 regularly spaced, thermodynamically stable stem-loops. Together, these findings suggest a promising new
nonprimate animal model and provide a database that will aid creation of functional NPHV cDNA clones and other novel tools
for hepacivirus studies.
The identification and characterization of animal virus ho-mologs provide insights into the pathogenesis of human-
pathogenic viruses and, in some instances, in vivo models for in-
vestigating prevention and treatment of human disease (41).
Well-characterized animal viruses include simian immunodefi-
ciency virus, animal poxviruses, herpesviruses, murine norovirus,
and woodchuck hepatitis virus (28). Hepatitis C virus (HCV), in
contrast, has few known animal relatives (3, 21). Moreover, HCV
naturally infects only humans and chimpanzees, resulting in a
paucity of animal models for studies of its pathogenesis, immu-
nity, and treatment (14, 26, 32, 40). An estimated 2% of the
world’s population is chronically infected with HCV. The ability
to study hepacivirus pathogenesis in more tractable animal mod-
els would dramatically enhance HCV research (14, 30).
The genus Hepacivirus, one of four genera in the family Flavi-
viridae, comprises HCV and GB virus B (GBV-B) (38). GBV-B
was isolated during laboratory passage of plasma from an individ-
ual with unexplained hepatitis through tamarins and other New
World monkey species but was never again recovered from a hu-
man sample (38). The natural host of GBV-B has thus remained
elusive (4, 5, 31, 38). We recently identified canine hepacivirus
(CHV) in respiratory samples of domestic dogs (21). CHV is the
first nonprimate hepacivirus (NPHV) discovered, and compara-
tive phylogenetic analysis confirmed it as the closest genetic rela-
tive of HCV described to date (3, 21). The envelope protein E2 of
HCV, for example, is among the most variable portions of its
genome, yet it has significant sequence similarity to CHV (21).
Furthermore, CHV was detected in canine hepatocytes, although
its link with hepatitis and the persistence of infection was not
studied (3).
Recent advances in sequencing technologies have helped iden-
tification of many highly divergent human and animal viruses,
including CHV (2, 18–24). However, detection of viral nucleic
acids alone, particularly in feces or respiratory samples where they
may simply represent ingested contaminants, is insufficient to es-
tablish infection, let alone disease association (7, 27). Similarly,
although the demonstration of specific adaptive immune re-
sponses against viral structural and nonstructural proteins cannot
in itself prove a causal relationship to disease, it does provide de-
finitive evidence of host infection (2, 7). Here, we describe the
usefulness of a sensitive serological assay (7–11) that can be
quickly established for new pathogens to screen different animal
species for evidence of virus infection and thereby for identifica-
tion of a novel virus’s natural reservoir and host range. Our serol-
ogy data indicated the presence of CHV-like viruses in horses and
led to the genetic characterization of eight novel and genetically
diverse nonprimate hepaciviruses (NPHVs).
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MATERIALS AND METHODS
Serum samples. Serum samples from different animal species included
sera of 80 dogs, 14 rabbits, 81 deer, 84 cows, and 103 horses. All were
residual samples collected for diagnostic or commercial use, and investi-
gators had no other sample identifiers, except that all animals were living
in the area of New York State. All serum samples were stored at 80°C,
thawed, and then left at 4°C prior to processing for luciferase immuno-
precipitation system (LIPS) analysis.
Generation of Ruc-CHV helicase antigen fusion constructs. The
template for NS3 serine protease/helicase coding sequence of CHV was
generated by reverse transcription-PCR (RT-PCR) amplification from a
respiratory sample of a dog (21). Due to the possibility of antibody cross-
reactivity with the HCV helicase gene, a previously described fragment
(11) encompassing the corresponding helicase region of humanHCVwas
also tested as an antigen control. The primer adapter sequences used to
clone each CHV protein fragment are as follows: for CHV NS3, 5=-GAG
GGATCCATACACTTCGCAGATATG-3= and 5=-GAGCTCGAGTCAG
GTGTTACAGTCAGTAAC-3=, and for CHV core, 5=-GAGGGATCCAG
TAATAAATCTAAAAAC-3= and 5=-GAGCTCGAGTCAGGCCTCTCCG
AAAGATAC-3=. Both protein fragments were subcloned downstream of
Renilla luciferase (Ruc) using the pREN2 vector (10). DNA sequencing
was used to confirm the integrity of the DNA constructs. The helicase
protein fragment ofCHVused in LIPS assay (amino acid positions 1173 to
1436 of AEC45560) was32% and28% different fromHCV genotypes
in nucleotide and protein sequences, respectively. Plasmid DNAwas then
prepared from these two different pREN2 expression vectors using a Qia-
gen Midi preparation kit. Following transfection of mammalian expres-
sion vectors, crude protein extracts were obtained as described for use as
antigen (8).
LIPS assays. Briefly, animal sera were processed in a 96-well format at
room temperature as previously described (6, 8, 9). Serum samples were
first diluted 1:10 in assay buffer A (50 mM Tris, pH 7.5, 100 mMNaCl, 5
mM MgCl2, 1% Triton X-100) using a 96-well polypropylene microtiter
plate. Antibody titers were measured by adding 40l of buffer A, 10l of
diluted sera (1-l equivalent), and 1 107 light units (LU) of each of the
Ruc-CHV and HCV helicase antigen fragments containing crude Cos1
cell extract to wells of a polypropylene plate and incubated for 60 min at
room temperature on a rotary shaker. Next, 5 l of a 30% suspension of
Ultralink protein A/G beads (Pierce Biotechnology, Rockford, IL) in
phosphate-buffered saline (PBS) was added to the bottom of each well of
a 96-well filterHTS plate (Millipore, Bedford,MA). To this filter plate, the
100-l antigen-antibody reaction mixture was transferred, and the plate
was incubated for 60 min at room temperature on a rotary shaker. The
washing steps of the retained protein A/G beads were performed on a
Biomek Workstation or Tecan plate washer with a vacuum manifold.
After the final wash, LU were measured in a Berthold LB 960 Centro
microplate luminometer (Berthold Technologies, BadWilbad, Germany)
using coelenterazine substrate mix (Promega, Madison, WI). All LU data
were obtained from the averages of at least two separate experiments.
GraphPad Prism software (SanDiego, CA)was used for statistical analysis
of LIPS data. For the calculation of sensitivity and specificity, a cutoff limit
was used, which was derived from the combined value of the mean value
plus 3 standard deviations (SD) of the replica samples containing only
buffer, Ruc extract, and protein A/G beads. Horse serum samples highly
positive for anti-CHV helicase antibodies were used as internal positive
controls to standardize the LIPS parameters for testing of all serum sam-
ples.
Screening for CHV-like viruses and quantitative PCR. All serum
samples were extracted using a Qiagen viral RNA extraction kit. Total
RNA was converted to cDNA using random primers and used in nested
PCR. The PCR assay for theCHV5=untranslated region (UTR) conserved
motifs used primers ak70F1/ak370R1 and ak70F2/ak370R2 in the first and
second rounds, respectively. The PCR assay for the CHV helicase gene
conserved motifs used primers ak4360F1/ak4640R1 and ak4360F2/
ak4640R2 in the first and second rounds, respectively. Details of primers
and PCR conditions used are available on request. All PCR products were
sequenced to confirm the presence of CHV-like viruses in the samples.
Quantitative PCR to determine theNPHVgenome copynumber in serum
samples was done using a TaqMan assay using primers (Qanti-5UF1,
GAGGGAGCTGRAATTCGTGAA, and Qanti-5UR1, GCAAGCATCCT
ATCAGACCGT) and probe (6-carboxyfluorescein [FAM])-CCACGAA
GGAAGGCGGGGGC-(black hole quencher 1a [BHQ1a]-FAM) target-
ing 5= UTR sequences. Plasmids containing the 5= UTRs of all eight
variants were used as controls to optimize the assay and determine its
sensitivity.
Genome sequencing and phylogenetic analysis. Sequences with sim-
ilarity to flaviviruses (sequences that showed expect [E] values of1010
in NCBI blastp using default parameters) were assembled against the pro-
totypeHCV strains. Gapswere filled by primerwalking, using specific and
degenerate flavivirus primers (21). Both termini of the genome were ac-
quired using rapid amplification of cDNA ends (RACE) (23). Thereafter,
sequence validity was tested in 4 genome coverage by classical dideoxy
Sanger sequencing. Nucleotide compositions of different flaviviruses
and NPHV were determined using EMBOSS compseq (http://emboss
.bioinformatics.nl/cgi-bin/emboss/compseq). Nucleotide (5= UTR) and
translated protein sequences (coding regions) were aligned using the pro-
gramMUSCLE as implemented in the SSE package (34). Sequence diver-
gence scan and summary values for different genome regions were gener-
ated by the program Sequence Distance in the SSE package (34). All
complete genome sequences were checked for recombination by using the
program Genetic Algorithm Recombination Detection (GARD) in the
Datamonkey package, which provides an interface with the HyPhy pro-
gram (25, 33). Default parameters were used with an HKY substitution
model and a gamma distribution of 6 discrete rate steps.
RNAstructure prediction. Independent of phylogenetic information,
the secondary structure of the NPHV 5= UTR RNA was modeled with
MFOLD. Labeling of the predicted structures in the 5= UTR followed
numbering used for reported homologous structures inHCVandGBV-B.
The NPHV genome sequence was analyzed for evidence of genome-scale
ordered RNA structure (GORS) by comparing folding energies of consec-
utive fragments of nucleotide sequence with random sequence order con-
trols using the program Folding Energy Scan in the SEE package (34).
Minimum folding energies (MFEs) of NPHVs were calculated by using
the default setting in the program UNAFOLD. MFE results were ex-
pressed as MFE differences (MFEDs), i.e., the percent difference between
the MFE of the native sequence and that of the mean value of the 50
sequence order-randomized controls.
RESULTS
Use of the LIPS to search CHV-related viruses in other animal
species. CHV, the only known nonprimate hepacivirus and the
virus phylogenetically most related to HCV, has the potential to
become a valuable model system to study infection by and patho-
genesis of hepaciviruses (3). A limited number of canine samples
were identified as CHV RNA positive in our previous study (21).
To conduct a more thorough survey to identify a repository of
CHV-infected samples, we employed the recently developed lu-
ciferase-based luciferase immunoprecipitation system (LIPS) se-
roscreening approach (7). Given the high genetic diversity ob-
served in other RNA viruses, including HCV, we used the
evolutionarily conserved CHV helicase protein as the target anti-
gen. The CHV serine protease/helicase (NS3) coding region cor-
responding to the highly immunogenic region of HCV helicase
protein (11) was cloned into pREN2 eukaryotic expression vector,
for recombinant expression of an NS3-Renilla luciferase fusion
protein in COS1 cells (6–10). CHV-luciferase fusion proteins spe-
cifically bound to antibodies immobilized on protein A/G beads
and were measured by a standard luciferase assay (Fig. 1A).
We tested serum samples of 80 dogs; surprisingly, all were neg-
Burbelo et al.
6172 jvi.asm.org Journal of Virology
ative. We then tested 81 deer, 84 cows, 103 horses, and 14 rabbits
for the presence of anti-CHV helicase IgG. Using a conservative
cutoff, high-titered IgG antibodies were detected in 35% of the
serum samples from horses, while serum from one cow also
showed intermediate reactivity (Fig. 1B). To examine possible an-
tigenic cross-reactivity, we tested the equine seropositive and se-
ronegative samples against helicase protein of HCV (11) and
found all these samples to be nonreactive (Fig. 1C). These sero-
logical results suggested infection of horses by a hepacivirus(es)
more closely related to CHV than HCV in the helicase protein.
Discovery of genetically diverse NPHVs in horses. Expecting
that, like HCV infection, hepacivirus infection in animals might
persist (30), we developed two broadly reactive PCR assays target-
ing highly conserved sequencemotifs in CHV5=UTR and helicase
to detect the genetically related hepacivirus genomic RNA in se-
rum samples of horses and cows. Of the 84 cow and 103 horse
serum samples tested, 8 horse samples were positive for hepacivi-
rus RNA. Initial sequencing identified a series of genetically di-
verse viruses. Comparison of the serological data with the PCR
results revealed that the 8 samples positive for hepacivirus RNA
were those highly reactive in the LIPS CHV-helicase assay (red
circles in Fig. 1B). The primer walking approach was then used to
acquire additional genomic sequences of all 8 hepacivirus vari-
ants. Since these viruses were found in a different natural host and
had substantial genetic diversity compared to CHV, we tentatively
named them nonprimate hepaciviruses (NPHVs 1 to 8).
Complete genomes and genetic diversity of NPHVs. We ac-
quired complete genomic sequences of all 8 NPHV variants
(GenBank sequence accession numbers JQ434001 to JQ434008)
directly fromhorse serum samples for the purpose of phylogenetic
classification and estimation of their genome-wide diversity.
Complete genome sequences of NPHV were almost completely
FIG 1 LIPS detection of robust anti-CHVNS3 antibody titers in horses. (A) Schematic of LIPS serological screening. Recombinant NS3 of CHVwas genetically
fused to the C terminus of Renilla luciferase (Ruc) and produced in Cos1 cells. The Ruc-NS3 protein extract was incubated with serum samples, Ruc-NS3
antibody complexes were then captured by protein A/G beads, and light units were measured. (B) LIPS detection of anti-NS3 CHV antibodies in different
samples, including 80 dogs, 14 rabbits, 81 deer, 84 cows, 99 U.S. horses, and 4 pooled horse serum samples from New Zealand. The antibody titers from each
sample are plotted in light units (LU) on a log10 scale on the y axis, and equine samples positive by PCR are colored red. (C) Heat map analysis of equine and
human samples for anti-CHV antibodies. Anti-CHVNS3-seronegative horse (n 20) and -seropositive horse (n 20) samples were analyzed for anti-CHV and
anti-HCVNS3 antibodies. Antibody titers against the antigens were log10 transformed, and the levels were then color coded as indicated by the scale on the right,
where signal intensities range from high (red) to low (green). Each individual row represents the antibody titers in a single serum sample.
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colinear, with four sites of 1- to 3-base insertions among variants
in the 5=UTRand three regions of 1- to 4-amino-acid insertions in
the coding region. Compared to the original CHV 5= UTR se-
quence, all NPHV variants were 17 bases longer in the 5= UTR,
indicating that the originally reported CHV genomic sequence
(JF744991) was likely incomplete at the 5= end. Our many at-
tempts to find the 3= UTR (X-tail) in all new NPHV genomes
remained unsuccessful. Moreover, unlike other hepaciviruses, the
3= termini of all eight NPHV genomes showed the presence of
poly(A) tails of variable lengths.
With the exception of the original CHV variants, which were
highly similar to NZP-1-GBX2 (maximum of 0.35% divergence),
the 8 horse-derived NPHV sequences showed moderate sequence
divergence from each other (6.4% to 17.2%) over the length of the
genome (mean, 14.0%). At the nucleotide level, sequences were
more divergent in the structural (S) and nonstructural (NS) gene
regions (encoding core, E1 and E2 proteins, and NS2-NS5B, re-
spectively) than in the 5= UTR (Fig. 2), although the S region
showed greater amino acid sequence divergence thandidNS genes
(6.7% compared to 4.0%, respectively). However, most sequence
diversity between NPHV variants occurred at synonymous sites
with extremely low dN/dS ratios (ratios of nonsynonymous to
synonymous substitutions) in both coding regions (0.057 and
0.030) (Fig. 2). These figures are conservative estimates because
calculated Jukes-Cantor-corrected synonymous distances of be-
tween 1 and 2 likely substantially underestimate the frequency of
multiple substitutions. Despite the differences in sequence vari-
ability between sequence regions, phylogenetic relationships be-
tween the 8 equine sequences and CHVwere consistent across the
genome (Fig. 2) with no bootstrap-supported changes in branch-
ing order indicative of recombination between NPHV variants
(39). Formal testing for the occurrence of recombination was car-
ried out using GARD in the Datamonkey package. One possible
recombination breakpoint was detected at position 3525 (P 
0.019). However, phylogenetic trees constructed by neighbor
joining using maximum composite likelihood distances of either
side of the proposed breakpoint (positions 3126 to 3525 and 3526
to 3925) were topologically identical with similar bootstrap sup-
port for branches and branch lengths.
Sequence diversity within NPHV was greater than subtype di-
FIG 2 Phylogenetic analysis, genetic composition, and genome-wide divergence scanning of the eight NPHV genomes (A) Neighbor-joining trees of nucleotide
sequences from different genome regions of NPHV and corresponding regions of HCV (genotypes 1a to 7a) and GBV-B. Trees were constructed from
Jukes-Cantor-corrected pairwise distances calculated using the program MEGA version 5 (34); data sets were bootstrap resampled 500 times to indicate
robustness of branching (values of 70% shown on branches). (B) Mean nucleotide pairwise distances (uncorrected, y axis) and ratios of synonymous to
nonsynonymous Jukes-Cantor distances (dN/dS) between horse-derived hepaciviruses in different genome regions (red bars). These values were compared with
equivalent calculations for GBV-C/HPgV (blue bars) and HCV (green bars). (C) Amino acid sequence divergence across the genome of horse-derived NPHV
sequences (top plot) and comparisonwithHCVandGBV-C/HPgV (middle and bottomplots, respectively) using 300-base fragments increasing by 9 bases across
each virus alignment (midpoint plotted on y axis, positions numbered using NXP-1-GBX2 as a reference sequence). Genome diagrams above each graph show
gene boundaries using the same x axis scale as that on the divergence graph.
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versity within HCV (mean pairwise distances in S and NS regions
ranged from 6 to 10% and 5 to 12% in representative subtypes 1a,
1b, and 6a, compared to 15% and 14% in NPHV, respectively).
NPHVdiversity in the two regions was, however, substantially less
than the mean divergence between HCV subtypes and genotypes
(24%/23% and 32%/34%, respectively). HCV additionally dif-
fered from NPHV in its greater frequency of nonsynonymous
substitutions; although less divergent overall, the mean diver-
gence within subtype amino acid sequences of 1a, 1b, and 6a in the
two regions (7.2% and 6.5%) was greater than that within NPHV
(6.7%and 4.0%). The pattern of diversitywas indeedmore similar
to that of GB virus C (GBV-C)/hepatitis G virus (29, 36, 37) or the
proposed revised name human pegivirus (HPgV) (38). Diversity
amonghuman variants occurred at a similar level (14%and 12.5%
nucleotide sequence divergence in S and NS regions, respectively)
and similarly low dN/dS ratios (0.063 and 0.029) (Fig. 2).
RNA secondary structures in the NPHV 5= UTR and coding
region. The availability of multiple sequences from NPHVs en-
abled verification and refinement of the 5= UTR secondary struc-
ture prediction as well as an exploration of the nature of large-
scale RNA structure in the coding part of the genome. The
additional 17 bases at the 5= end of the 5=UTR extend the terminal
loop, creating a conserved, thermodynamically supported struc-
ture among a clear majority of predicted energetically most fa-
vored sequences and the first four suboptimal folding sequences
of the 6 sequences complete to the 5= end. This stem-loop is both
larger and more conserved than the structure found within the
homologous region in HCV. 5= UTR sequences showed a mean
divergence of approximately 4% between horse-derived NPHV
variants, and the distribution of this variability was investigated to
determine whether substitutions could be accommodated within
the previously proposed secondary structure (Fig. 3A) (21). Most
of the 44 polymorphic sites occurred in regions of no predicted
base-pairing (n  26; 59% [green boxes]). All but two of the
remainder were covariant (i.e., substitutions occurred in pairs to
maintain base-pairing; n  6) or semicovariant (G-C↔ G-U or
A-U ↔ G-U; n  10). All insertions/deletions (green triangles)
occurred in unpaired loop regions (in stem-loops II and IIIb) or
could be accommodated through changing pairing partners
(stem-loop I) (Fig. 3A).
Variability in the 5=UTR sequences was concentrated in stem-
loops II and IIIb and the region homologous to themicroRNA122
(miRNA-122) binding site 1 in HCV (17, 21). In general, regions
that were conserved between NPHV and HCV (blue circles) were
invariant between NPHV variants, while other regions such as the
IIIb terminal region were variable in both sequence and length in
FIG 3 RNA structure analysis of NPHV 5= UTR and complete genomes. (A) Predicted RNA structure for the 5= UTR of NPHV based on minimum free energy
predictions and comparison with homologous sequences of HCV and GBV-B (21). Bases were numbered using NXP-1-GBX2 as a reference sequence; stem-
loops were numbered as in reference 16. Sequences homologous to targets of miRNA-122 (17) are indicated by heavy lines. (B and C) Secondary structure
prediction for NPHV genome sequences usingmeanMFED differences (y axis) of 200- and 250-base fragments (30-base increment; midpoint plotted on x axis)
for CHV and the 8 horse-derived hepacivirus sequences (B) and analysis of the 8 NPHV sequences by ALIFOLD using default parameters (C) (see reference 31
for explanation of color coding). Due to restriction in the server, this figure was built as a composite of 6 separate overlapping 2,000-base fragments increasing
by 1,500 bases (C).
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both viruses (Fig. 3A). Regions of the internal ribosome entry site
(IRES) with known or suspected functional roles in ribosome
binding/translation initiationwere invariant inNPHVandmostly
identical in sequence to homologous regions in HCV (16). The
exception was the base-paired region between position 5=-185-
193 and 5=-357-365, which was nonhomologous to paired base
regions in HCV.
Sequence variability and the use of phylogenetic information
(such as the occurrence of covariant sites) were used to explore
RNA secondary structure in the coding region of the genome (Fig.
3B). Previous thermodynamic folding analysis of the CHV ge-
nome revealed a 14% free energy difference between its minimum
folding energy (MFE) and that of sequence order-randomized
controls, observations consistent with the presence of genome-
scale ordered RNA structure in the CHV genome (21). MFE dif-
ferences (MFEDs) in the coding region of the 8 horse-derived
hepacivirus sequences ranged from 12.5% to 13.9% (mean,
13.0%).MFEDs of successive fragments with lengths between 250
and 400 bases revealed the presence of 27 regularly spaced stem-
loops running through the coding part of the genome (Fig. 3B).
Mean stem-loop separations (between peak MFED values) were
295 (standard deviation, 80) and 306 (71) bases in separate
analyses using fragment lengths of 250 and 200 bases, respectively,
for scanning. Positions and spacing of structures predicted by
MFED scanning were consistent with ALIFOLD (15), which com-
putes pairing likelihoods based on phylogenetic conservation and
covariance weighted structure prediction on an underlying ther-
modynamic model (Fig. 3C). Through analysis of the predicted
pairings, the substantial sequence diversity between NPHV se-
quences in coding regions (14%) was compensated by semicova-
riant and fully covariant sites and concentration of polymor-
phisms in predicted unpaired terminal loop regions analogous to
the pattern observed in the 5= UTR. A full analysis of the coding
region of NPHV and other viruses with large-scale RNA second-
ary is in preparation.
DISCUSSION
HCV and its genetically related viruses were considered to be re-
stricted to primates until the recent discovery of CHV indicated a
wider host range (3, 21). Initially, CHVwas found in dogs, but our
subsequent efforts to find similar viruses in canids remained
largely unsuccessful. To explore the hypothesis that the natural
host of CHVwas indeed anothermammalian species (and that the
outbreaks of infection in dog kennels were due to cross-species
virus transmission), a wide range of other nonprimate animal spe-
cies were tested. We chose to use serology for its advantages of
tolerance for sequence divergence, a capacity to detect resolved as
well as acute or active infections, and high sample throughput.We
expected that like other RNA viruses, including HCV, different
CHV variants would be genetically diverse, and we therefore syn-
thesized antigen from the helicase domain of NS3, the most con-
served viral protein in the genome and one that shows docu-
mented antigenicity in HCV (11).
Serology provided evidence of CHV-like virus infection of
horses that was confirmed by the detection of diverse viral ge-
nomes in 8 of the 36 samples with anti-NS3 reactivity. Horses are
also known to support replication of several other flaviviruses,
including the vector-borneWest Nile virus, Japanese encephalitis
virus, dengue virus, and St. Louis encephalitis virus, which are
transmitted between several mammalian species, including hu-
mans (1, 12). Although most of the NPHV variants detected in
horses were genetically distinct from CHV infecting dogs, one
found in a commercial horse serumpool (fromNewZealand) was
almost identical to CHV, providing direct evidence for an ability
of NPHV to jump species. We tested all the dog serum samples
with PCR and found no positives; however, the absence of NPHV
infection in dogs from a specific geographical location might not
represent the global ecology of NPHV and should be studied fur-
ther. NPHV genomes were not detected in any of the 83 cow
serum samples despite rare seropositivity (Fig. 1B), suggesting ei-
ther further cross-species transmission events or widespread dis-
tribution of further, potentially equally diverse NPHV variants.
The frequent detection of viremia in seropositive horses (22%)
provides evidence that infections were persistent (copresence of
IgG antibodies and viral genomes). In this respect,NHPV is unlike
HCV, which persistently infects over 50% of humans exposed,
and more similar to GBV-C/HPgV (approximately 25% persis-
tence). Although our failure to detect viral sequences inmore than
half of the seropositive horses may reflect sequence divergence
that confounds consensus PCR, we have an alternative hypothesis
whereby NPHVmay be cleared in the majority of equine hosts. If
confirmed, investigation of the mechanism by which this occurs
could yield insights that will lead to new strategies for manage-
ment of human HCV infection.
Comparative sequence analysis of related viruses can be used to
identify evolutionarily conserved and therefore functionally im-
portant genomic regions. Particularly striking was the predicted
secondary and pseudoknot (tertiary) structure of the 5= UTR of
NPHV and its structural conservation with homologous regions
in HCV and GBV-B (Fig. 3A). Although the validity of structure
predictions in this region requires verification by nuclease map-
ping or by the more recently developed SHAPE (selective 2=-hy-
droxyl acylation analyzed by primer extension) analysis methods,
the pattern of sequence changes (the occurrence of multiple cova-
riant and semicovariant changes in predicted paired regions and
the restriction of noncompensated substitutions to unpaired re-
gions) provides strong evolutionary support for the proposed
structure model. Most evident was the structural similarity of the
stem-loop III region ofNPHV tohomologous regions forming the
IRES in HCV and pestiviruses and type IV IRESs in picornavi-
ruses. Anunexpected structural difference existed, however, in the
extreme 5= end of the 5= UTR. Sequence similarity to the equiva-
lent, much shorter region in HCV (16 bases) diminished in the
first 74 bases of the NPHV 5= UTR sequence. NPHV forms a pre-
dicted thermodynamically stable stem-loop encompassing posi-
tions 2 to 74 that is much larger than that described in the equiv-
alent region of HCV. While the distribution of covariant and
noncompensated substitutions supports the NPHV structure
model, the existence of potential alternative pairing in a propor-
tion of suboptimal folds of this region and the striking structural
difference fromHCVrequire that the region be physicallymapped
to verify the structure predictions.
The HCV 5= UTR contains two miRNA-122 binding sites that
are highly conserved among all genotypes and required for repli-
cation in liver cells. While the original predicted secondary struc-
ture of the CHV 5= UTR showed occlusion of both miRNA-122
binding sites (21), the availability of likely more complete se-
quences from NPHV allowed some modification and refinement
of the 5=UTR secondary structure prediction. In the revised struc-
ture of the NHPV 5= UTR, the second miRNA-122 seed site was
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both open and completely conserved (Fig. 3A). Given the tissue-
specific expression ofmiRNA-122 in the liver and the potential for
an equivalent cooperative interaction between NPHV and the
horse homolog of miRNA-122, these findings suggest hepatotro-
pism comparable to that of HCV. At this stage, however, we have
no experimental data to support the specific targeting of the liver
by NPHV in vivo, and this represents a major priority in ongoing
studies.
MFED scanning implemented in the SSE package has been
used to document the presence of genome-scale ordered RNA
structure (GORS) in RNA virus genomes (35). MFEDs averaged
over the NPHV genomes fell into a relatively narrow range from
12.5% to 13.9% (mean, 13.0%), similar to that described for CHV
and consistently higher than those for HCV, human and simian
GB viruses/pegiviruses, and most other RNA viruses (21, 35). De-
tection of high MFED values, restricted generally to viruses that
establish persistence in their natural hosts (35), is consistent with
the observation that over 20%of exposed horses were viremic (see
discussion above). Scanning sequences using fragments compara-
ble to the lengths of stem-loops in the NPHV genome produced a
plot comprising regularly spaced peaks of highMFED values (cor-
responding to fragments containing the 5= and 3= sides of the
stem-loop) alternating with fragments of low folding energy, rep-
resenting folding energies of naturally nonpairing sequences from
the 3= side of one stem-loop and the 5= side of the next. This
revealed the presence of a series of quite regularly spaced stem-
loops running through the whole coding sequence of NPHV, an
RNA structure that is likely to substantially modify the structural
configuration of the genomic RNA, as demonstrated for other
viruses with GORS (13), and potentially modulates its interaction
with host cell defenses in a way that promotes virus persistence, as
previously hypothesized (15). The substantial diversity at third
codon positions and the likely conservation of RNA structure
between NPHV variants enabled use of structure prediction pro-
grams that exploit phylogenetic information such as pairing part-
ners and the occurrence of covariant sites to validate thermody-
namic predictions. The mountain plot produced by ALIFOLD
(15) closely reproduced the peak and trough prediction of the
MFED scan. The concordance between predictions from two dif-
ferent RNA structure predictionmethods recapitulates the results
of previous detailed analysis of predicted unstructured and struc-
tured viral genomes (13). This showed substantial, algorithm-in-
dependent concordance betweenMFED, ALIFOLD, PFOLD, and
RNAz methods in their prediction of both the presence and the
intensity of RNA pairing in an extended viral sequence data set.
Furthermore, viral genomes predicted to be structured showed a
range of biophysical differences from unstructured virus, includ-
ing hybridization accessibility and scanning electron microscopy
appearance (13). From these previous data, we can expect the
NPHV genome to be extensively internally base-paired and to
share a closed genomic configuration that maymodulate its inter-
action with host cell defenses (13, 35). For future analysis, the
comparative sequence data from the 8 complete genomes of
NPHV indeed provide a wealth of sequence data to validate RNA
pairing predictions, analyze the evolutionary conservation of
paired and unpaired sites, and explore the relationship between
sequence change and evolution of RNA structures that preserve
secondary structure and closed genomic RNA configurations that
seem central to its role in persistence.
Similarities and differences between HCV and NPHV will be
equally informative with respect to hepacivirus biology. If NPHV
resembles HCV in its pathogenesis, it could lead to a tractable in
vivomodel for the human virus. Where the species diverge, it will
provide a unique opportunity to compare the molecular and cel-
lular bases for those differences. The ability to compare closely
related hepaciviruses in vitro will provide insights into the molec-
ular biology of both viruses. Features such as entry factors, inter-
actions of viral and host proteins, and the regulation of replication
by genomic elements can be pursued. Moreover, an infectious
clone for NPHV will pave the way for experimental animal infec-
tions. The data presented here will help in generating an NPHV
consensus sequence from multiple isolated sequences. As for
HCV, we expect that a consensus clone will be useful in recapitu-
lating replication and potentially infectious virus production in
cultured cells. Ultimately, these NPHV infectious clonesmay pro-
vide an ideal backbone for the development of recombinant HCV
vaccines. Together, our data will assist in the design of studies to
illuminate hepacivirus biology from a new angle. The availability
of genetically distinct NPHV genomes and analysis of their evolu-
tionary change and constraints and similarities and differences
from the evolutionary processes reconstructed for HCV will
therefore likely advance our understanding of the role that these
genetic elements and proteins play in the viral life cycle, epidemi-
ology, and pathogenesis.
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